KOLOA, Hawaii — Despite fixed, frequent dosing being optimal for wet age-related macular degeneration management, ophthalmologists tend to favor non-fixed regimens like treat-and-extend in clinical practice, according to a presenter at Retina 2020.
Michael S. Ip, MD, believes this is because fixed, frequent dosing is a treatment burden. This dosing regimen is also difficult to apply and expensive, he said.
“We’ve searched long and hard to prove that non-fixed regimens may be effective,” Ip said.
Evidence from several published studies, both retrospective and prospective,
Uncategorized